Seaport Therapeutics SPTX Cash Flow Statement
| Q1 '26 | ||
|---|---|---|
| -$25.41M-93.6% | ||
| $26K-27.8% | ||
| $2.57M+58.7% | ||
| -$20.17M+0.2% | ||
| $0-100% | ||
| $27.85M+112% | ||
| -$783K— | ||
| $6.87M+103% | ||
| -$20.17M+0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Seaport Therapeutics 's cash flow data come from?
- Every line is extracted from Seaport Therapeutics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.